NTRK2 and psychiatric disorder: TrkB-D5 is considered as a favorable target for neurological and psychiatric disorder agonists, which bind to this TrkB domain to mimic the binding of Brain-Derived Neurotrophic Factor (BDNF) [38,39,40,41,42].